-
Before giving a stroke patient tissue plasminogen activator (tPA), you must consider not only whether the patent is a candidate, but also whether the setting is appropriate, says Edward Jauch, MD, MS, assistant professor in the department of emergency medicine at University of Cincinnati and a member of the Greater Cincinnati/Northern Kentucky Stroke Team.
-
Imagine this e-mail from one of your colleagues being Exhibit A at your malpractice trial: "You misdiagnosed Jane Doe with indigestion last night and she showed up this morning on my shift with a heart attack and didn't live. Since this is your third time to miss this sort of thing, you really need to pay better attention."
-
The availability of genetic testing is expanding rapidly so rapidly that information is available before there are safeguards in place concerning how it can be used. In recent months, home test kits, with which users are told they can determine genetic predisposition to bipolar disorders or determine paternity, have come on the market.
-
Nearly 47 million Americans lack health insurance, leaving them without regular access to health care and making them a potentially vulnerable population in health care research.
-
'Dr. Death' seeks to become Rep. Kevorkian, Antibiotics and end-of-life in dementia patients
-
When the first psychiatric advance directives (PADs) began to appear in state legislation more than 20 years ago, they were largely considered to be an end-of-life tool, much like general advance directives. But as more states have passed PAD laws 25 states now have laws specifically providing for PADs their usefulness has expanded.
-
The life cycle of a vaccine from discovery and production through distribution, rationing, and replacement can span a quarter-century, involve health professionals worldwide, and raise ethical issues every step of the way. But there was no centralized effort to promote policy and ethics around vaccine discovery, use, and global public health and so the Center for Vaccine Ethics and Policy was created.
-
Some lawmakers in Massachusetts have introduced legislation that would make the state the first in the nation to impose an outright ban on all pharmaceutical marketing gifts to physicians. The bill also seeks statewide adoption of electronic medical records.
-
The health care community has long endorsed staff and patients speaking up when necessary to protect patient safety, but in the heat of the moment, a staff member can be intimidated by superiors and fearful of rocking the boat.
-
Before you hand patients free samples of prescription drugs, consider that the sample that saves them money now may end up costing them in the long run, according to research that indicates patients who receive free drug samples from their doctors have significantly higher out-of-pocket prescription costs than those who don't.
